Recombinant Protein Vaccine Market, Global Outlook and Forecast 2022-2028
Recombinant Protein Vaccine refers to the vaccines manufactured using recombinant DNA technology
This report contains market size and forecasts of Recombinant Protein Vaccine in global, including the following market information:
Global Recombinant Protein Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Protein Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Recombinant Protein Vaccine companies in 2021 (%)
The global Recombinant Protein Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bacterial Cells Culture Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Protein Vaccine include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences and Novavax and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Protein Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Protein Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Protein Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Recombinant Protein Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Recombinant Protein Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Recombinant Protein Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Protein Vaccine revenues share in global market, 2021 (%)
Key companies Recombinant Protein Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Recombinant Protein Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Recombinant Protein Vaccine in global, including the following market information:
Global Recombinant Protein Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Protein Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Recombinant Protein Vaccine companies in 2021 (%)
The global Recombinant Protein Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bacterial Cells Culture Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Protein Vaccine include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences and Novavax and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Protein Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Protein Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Protein Vaccine Market Segment Percentages, by Type, 2021 (%)
- Bacterial Cells Culture
- Mammalian Cells Culture
Global Recombinant Protein Vaccine Market Segment Percentages, by Application, 2021 (%)
- Human
- Animal
Global Recombinant Protein Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Recombinant Protein Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Protein Vaccine revenues share in global market, 2021 (%)
Key companies Recombinant Protein Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Recombinant Protein Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- GSK
- Sanofi
- Zoties
- Elanco
- Boehringer-Ingelheim
- Indian Immunologicals
- Plumbline Life Sciences
- Novavax
- Medicago
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Recombinant Protein Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Protein Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RECOMBINANT PROTEIN VACCINE OVERALL MARKET SIZE
2.1 Global Recombinant Protein Vaccine Market Size: 2021 VS 2028
2.2 Global Recombinant Protein Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Protein Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Recombinant Protein Vaccine Players in Global Market
3.2 Top Global Recombinant Protein Vaccine Companies Ranked by Revenue
3.3 Global Recombinant Protein Vaccine Revenue by Companies
3.4 Global Recombinant Protein Vaccine Sales by Companies
3.5 Global Recombinant Protein Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Protein Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Protein Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Protein Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Protein Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Protein Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Recombinant Protein Vaccine Market Size Markets, 2021 & 2028
4.1.2 Bacterial Cells Culture
4.1.3 Mammalian Cells Culture
4.2 By Type - Global Recombinant Protein Vaccine Revenue & Forecasts
4.2.1 By Type - Global Recombinant Protein Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Protein Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Protein Vaccine Sales & Forecasts
4.3.1 By Type - Global Recombinant Protein Vaccine Sales, 2017-2022
4.3.2 By Type - Global Recombinant Protein Vaccine Sales, 2023-2028
4.3.3 By Type - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Protein Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Recombinant Protein Vaccine Market Size, 2021 & 2028
5.1.2 Human
5.1.3 Animal
5.2 By Application - Global Recombinant Protein Vaccine Revenue & Forecasts
5.2.1 By Application - Global Recombinant Protein Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Protein Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Protein Vaccine Sales & Forecasts
5.3.1 By Application - Global Recombinant Protein Vaccine Sales, 2017-2022
5.3.2 By Application - Global Recombinant Protein Vaccine Sales, 2023-2028
5.3.3 By Application - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Protein Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Recombinant Protein Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Protein Vaccine Revenue & Forecasts
6.2.1 By Region - Global Recombinant Protein Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Protein Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Protein Vaccine Sales & Forecasts
6.3.1 By Region - Global Recombinant Protein Vaccine Sales, 2017-2022
6.3.2 By Region - Global Recombinant Protein Vaccine Sales, 2023-2028
6.3.3 By Region - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Protein Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Protein Vaccine Sales, 2017-2028
6.4.3 US Recombinant Protein Vaccine Market Size, 2017-2028
6.4.4 Canada Recombinant Protein Vaccine Market Size, 2017-2028
6.4.5 Mexico Recombinant Protein Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Protein Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Protein Vaccine Sales, 2017-2028
6.5.3 Germany Recombinant Protein Vaccine Market Size, 2017-2028
6.5.4 France Recombinant Protein Vaccine Market Size, 2017-2028
6.5.5 U.K. Recombinant Protein Vaccine Market Size, 2017-2028
6.5.6 Italy Recombinant Protein Vaccine Market Size, 2017-2028
6.5.7 Russia Recombinant Protein Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Protein Vaccine Market Size, 2017-2028
6.5.9 Benelux Recombinant Protein Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Protein Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Protein Vaccine Sales, 2017-2028
6.6.3 China Recombinant Protein Vaccine Market Size, 2017-2028
6.6.4 Japan Recombinant Protein Vaccine Market Size, 2017-2028
6.6.5 South Korea Recombinant Protein Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Protein Vaccine Market Size, 2017-2028
6.6.7 India Recombinant Protein Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Protein Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Protein Vaccine Sales, 2017-2028
6.7.3 Brazil Recombinant Protein Vaccine Market Size, 2017-2028
6.7.4 Argentina Recombinant Protein Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Protein Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Protein Vaccine Sales, 2017-2028
6.8.3 Turkey Recombinant Protein Vaccine Market Size, 2017-2028
6.8.4 Israel Recombinant Protein Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Protein Vaccine Market Size, 2017-2028
6.8.6 UAE Recombinant Protein Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Recombinant Protein Vaccine Major Product Offerings
7.1.4 Merck Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Recombinant Protein Vaccine Major Product Offerings
7.2.4 GSK Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Recombinant Protein Vaccine Major Product Offerings
7.3.4 Sanofi Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Zoties
7.4.1 Zoties Corporate Summary
7.4.2 Zoties Business Overview
7.4.3 Zoties Recombinant Protein Vaccine Major Product Offerings
7.4.4 Zoties Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Zoties Key News
7.5 Elanco
7.5.1 Elanco Corporate Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Recombinant Protein Vaccine Major Product Offerings
7.5.4 Elanco Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Elanco Key News
7.6 Boehringer-Ingelheim
7.6.1 Boehringer-Ingelheim Corporate Summary
7.6.2 Boehringer-Ingelheim Business Overview
7.6.3 Boehringer-Ingelheim Recombinant Protein Vaccine Major Product Offerings
7.6.4 Boehringer-Ingelheim Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Boehringer-Ingelheim Key News
7.7 Indian Immunologicals
7.7.1 Indian Immunologicals Corporate Summary
7.7.2 Indian Immunologicals Business Overview
7.7.3 Indian Immunologicals Recombinant Protein Vaccine Major Product Offerings
7.7.4 Indian Immunologicals Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Indian Immunologicals Key News
7.8 Plumbline Life Sciences
7.8.1 Plumbline Life Sciences Corporate Summary
7.8.2 Plumbline Life Sciences Business Overview
7.8.3 Plumbline Life Sciences Recombinant Protein Vaccine Major Product Offerings
7.8.4 Plumbline Life Sciences Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Plumbline Life Sciences Key News
7.9 Novavax
7.9.1 Novavax Corporate Summary
7.9.2 Novavax Business Overview
7.9.3 Novavax Recombinant Protein Vaccine Major Product Offerings
7.9.4 Novavax Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Novavax Key News
7.10 Medicago
7.10.1 Medicago Corporate Summary
7.10.2 Medicago Business Overview
7.10.3 Medicago Recombinant Protein Vaccine Major Product Offerings
7.10.4 Medicago Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Medicago Key News
8 GLOBAL RECOMBINANT PROTEIN VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Recombinant Protein Vaccine Production Capacity, 2017-2028
8.2 Recombinant Protein Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Protein Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RECOMBINANT PROTEIN VACCINE SUPPLY CHAIN ANALYSIS
10.1 Recombinant Protein Vaccine Industry Value Chain
10.2 Recombinant Protein Vaccine Upstream Market
10.3 Recombinant Protein Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Protein Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Recombinant Protein Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Protein Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RECOMBINANT PROTEIN VACCINE OVERALL MARKET SIZE
2.1 Global Recombinant Protein Vaccine Market Size: 2021 VS 2028
2.2 Global Recombinant Protein Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Protein Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Recombinant Protein Vaccine Players in Global Market
3.2 Top Global Recombinant Protein Vaccine Companies Ranked by Revenue
3.3 Global Recombinant Protein Vaccine Revenue by Companies
3.4 Global Recombinant Protein Vaccine Sales by Companies
3.5 Global Recombinant Protein Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Protein Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Protein Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Protein Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Protein Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Protein Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Recombinant Protein Vaccine Market Size Markets, 2021 & 2028
4.1.2 Bacterial Cells Culture
4.1.3 Mammalian Cells Culture
4.2 By Type - Global Recombinant Protein Vaccine Revenue & Forecasts
4.2.1 By Type - Global Recombinant Protein Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Protein Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Protein Vaccine Sales & Forecasts
4.3.1 By Type - Global Recombinant Protein Vaccine Sales, 2017-2022
4.3.2 By Type - Global Recombinant Protein Vaccine Sales, 2023-2028
4.3.3 By Type - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Protein Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Recombinant Protein Vaccine Market Size, 2021 & 2028
5.1.2 Human
5.1.3 Animal
5.2 By Application - Global Recombinant Protein Vaccine Revenue & Forecasts
5.2.1 By Application - Global Recombinant Protein Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Protein Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Protein Vaccine Sales & Forecasts
5.3.1 By Application - Global Recombinant Protein Vaccine Sales, 2017-2022
5.3.2 By Application - Global Recombinant Protein Vaccine Sales, 2023-2028
5.3.3 By Application - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Protein Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Recombinant Protein Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Protein Vaccine Revenue & Forecasts
6.2.1 By Region - Global Recombinant Protein Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Protein Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Protein Vaccine Sales & Forecasts
6.3.1 By Region - Global Recombinant Protein Vaccine Sales, 2017-2022
6.3.2 By Region - Global Recombinant Protein Vaccine Sales, 2023-2028
6.3.3 By Region - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Protein Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Protein Vaccine Sales, 2017-2028
6.4.3 US Recombinant Protein Vaccine Market Size, 2017-2028
6.4.4 Canada Recombinant Protein Vaccine Market Size, 2017-2028
6.4.5 Mexico Recombinant Protein Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Protein Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Protein Vaccine Sales, 2017-2028
6.5.3 Germany Recombinant Protein Vaccine Market Size, 2017-2028
6.5.4 France Recombinant Protein Vaccine Market Size, 2017-2028
6.5.5 U.K. Recombinant Protein Vaccine Market Size, 2017-2028
6.5.6 Italy Recombinant Protein Vaccine Market Size, 2017-2028
6.5.7 Russia Recombinant Protein Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Protein Vaccine Market Size, 2017-2028
6.5.9 Benelux Recombinant Protein Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Protein Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Protein Vaccine Sales, 2017-2028
6.6.3 China Recombinant Protein Vaccine Market Size, 2017-2028
6.6.4 Japan Recombinant Protein Vaccine Market Size, 2017-2028
6.6.5 South Korea Recombinant Protein Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Protein Vaccine Market Size, 2017-2028
6.6.7 India Recombinant Protein Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Protein Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Protein Vaccine Sales, 2017-2028
6.7.3 Brazil Recombinant Protein Vaccine Market Size, 2017-2028
6.7.4 Argentina Recombinant Protein Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Protein Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Protein Vaccine Sales, 2017-2028
6.8.3 Turkey Recombinant Protein Vaccine Market Size, 2017-2028
6.8.4 Israel Recombinant Protein Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Protein Vaccine Market Size, 2017-2028
6.8.6 UAE Recombinant Protein Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Recombinant Protein Vaccine Major Product Offerings
7.1.4 Merck Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Recombinant Protein Vaccine Major Product Offerings
7.2.4 GSK Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Recombinant Protein Vaccine Major Product Offerings
7.3.4 Sanofi Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Zoties
7.4.1 Zoties Corporate Summary
7.4.2 Zoties Business Overview
7.4.3 Zoties Recombinant Protein Vaccine Major Product Offerings
7.4.4 Zoties Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Zoties Key News
7.5 Elanco
7.5.1 Elanco Corporate Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Recombinant Protein Vaccine Major Product Offerings
7.5.4 Elanco Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Elanco Key News
7.6 Boehringer-Ingelheim
7.6.1 Boehringer-Ingelheim Corporate Summary
7.6.2 Boehringer-Ingelheim Business Overview
7.6.3 Boehringer-Ingelheim Recombinant Protein Vaccine Major Product Offerings
7.6.4 Boehringer-Ingelheim Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Boehringer-Ingelheim Key News
7.7 Indian Immunologicals
7.7.1 Indian Immunologicals Corporate Summary
7.7.2 Indian Immunologicals Business Overview
7.7.3 Indian Immunologicals Recombinant Protein Vaccine Major Product Offerings
7.7.4 Indian Immunologicals Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Indian Immunologicals Key News
7.8 Plumbline Life Sciences
7.8.1 Plumbline Life Sciences Corporate Summary
7.8.2 Plumbline Life Sciences Business Overview
7.8.3 Plumbline Life Sciences Recombinant Protein Vaccine Major Product Offerings
7.8.4 Plumbline Life Sciences Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Plumbline Life Sciences Key News
7.9 Novavax
7.9.1 Novavax Corporate Summary
7.9.2 Novavax Business Overview
7.9.3 Novavax Recombinant Protein Vaccine Major Product Offerings
7.9.4 Novavax Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Novavax Key News
7.10 Medicago
7.10.1 Medicago Corporate Summary
7.10.2 Medicago Business Overview
7.10.3 Medicago Recombinant Protein Vaccine Major Product Offerings
7.10.4 Medicago Recombinant Protein Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Medicago Key News
8 GLOBAL RECOMBINANT PROTEIN VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Recombinant Protein Vaccine Production Capacity, 2017-2028
8.2 Recombinant Protein Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Protein Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RECOMBINANT PROTEIN VACCINE SUPPLY CHAIN ANALYSIS
10.1 Recombinant Protein Vaccine Industry Value Chain
10.2 Recombinant Protein Vaccine Upstream Market
10.3 Recombinant Protein Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Protein Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Recombinant Protein Vaccine in Global Market
Table 2. Top Recombinant Protein Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Protein Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Protein Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Protein Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Recombinant Protein Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Protein Vaccine Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Recombinant Protein Vaccine Product Type
Table 9. List of Global Tier 1 Recombinant Protein Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Protein Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Protein Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Recombinant Protein Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Recombinant Protein Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Protein Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Recombinant Protein Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Recombinant Protein Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Protein Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Recombinant Protein Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Recombinant Protein Vaccine Product Offerings
Table 48. Merck Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Recombinant Protein Vaccine Product Offerings
Table 51. GSK Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Recombinant Protein Vaccine Product Offerings
Table 54. Sanofi Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Zoties Corporate Summary
Table 56. Zoties Recombinant Protein Vaccine Product Offerings
Table 57. Zoties Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Elanco Corporate Summary
Table 59. Elanco Recombinant Protein Vaccine Product Offerings
Table 60. Elanco Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Boehringer-Ingelheim Corporate Summary
Table 62. Boehringer-Ingelheim Recombinant Protein Vaccine Product Offerings
Table 63. Boehringer-Ingelheim Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Indian Immunologicals Corporate Summary
Table 65. Indian Immunologicals Recombinant Protein Vaccine Product Offerings
Table 66. Indian Immunologicals Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Plumbline Life Sciences Corporate Summary
Table 68. Plumbline Life Sciences Recombinant Protein Vaccine Product Offerings
Table 69. Plumbline Life Sciences Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Novavax Corporate Summary
Table 71. Novavax Recombinant Protein Vaccine Product Offerings
Table 72. Novavax Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Medicago Corporate Summary
Table 74. Medicago Recombinant Protein Vaccine Product Offerings
Table 75. Medicago Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Recombinant Protein Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Recombinant Protein Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Recombinant Protein Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Recombinant Protein Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Recombinant Protein Vaccine Market Opportunities & Trends in Global Market
Table 81. Recombinant Protein Vaccine Market Drivers in Global Market
Table 82. Recombinant Protein Vaccine Market Restraints in Global Market
Table 83. Recombinant Protein Vaccine Raw Materials
Table 84. Recombinant Protein Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Recombinant Protein Vaccine Downstream
Table 86. Recombinant Protein Vaccine Downstream Clients in Global Market
Table 87. Recombinant Protein Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Recombinant Protein Vaccine in Global Market
Table 2. Top Recombinant Protein Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Protein Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Protein Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Protein Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Recombinant Protein Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Protein Vaccine Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Recombinant Protein Vaccine Product Type
Table 9. List of Global Tier 1 Recombinant Protein Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Protein Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Protein Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Recombinant Protein Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Recombinant Protein Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Protein Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Recombinant Protein Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Recombinant Protein Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Protein Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Protein Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Recombinant Protein Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Protein Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Protein Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Protein Vaccine Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Recombinant Protein Vaccine Product Offerings
Table 48. Merck Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Recombinant Protein Vaccine Product Offerings
Table 51. GSK Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Recombinant Protein Vaccine Product Offerings
Table 54. Sanofi Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Zoties Corporate Summary
Table 56. Zoties Recombinant Protein Vaccine Product Offerings
Table 57. Zoties Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Elanco Corporate Summary
Table 59. Elanco Recombinant Protein Vaccine Product Offerings
Table 60. Elanco Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Boehringer-Ingelheim Corporate Summary
Table 62. Boehringer-Ingelheim Recombinant Protein Vaccine Product Offerings
Table 63. Boehringer-Ingelheim Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Indian Immunologicals Corporate Summary
Table 65. Indian Immunologicals Recombinant Protein Vaccine Product Offerings
Table 66. Indian Immunologicals Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Plumbline Life Sciences Corporate Summary
Table 68. Plumbline Life Sciences Recombinant Protein Vaccine Product Offerings
Table 69. Plumbline Life Sciences Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Novavax Corporate Summary
Table 71. Novavax Recombinant Protein Vaccine Product Offerings
Table 72. Novavax Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Medicago Corporate Summary
Table 74. Medicago Recombinant Protein Vaccine Product Offerings
Table 75. Medicago Recombinant Protein Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Recombinant Protein Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Recombinant Protein Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Recombinant Protein Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Recombinant Protein Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Recombinant Protein Vaccine Market Opportunities & Trends in Global Market
Table 81. Recombinant Protein Vaccine Market Drivers in Global Market
Table 82. Recombinant Protein Vaccine Market Restraints in Global Market
Table 83. Recombinant Protein Vaccine Raw Materials
Table 84. Recombinant Protein Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Recombinant Protein Vaccine Downstream
Table 86. Recombinant Protein Vaccine Downstream Clients in Global Market
Table 87. Recombinant Protein Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Recombinant Protein Vaccine Segment by Type
Figure 2. Recombinant Protein Vaccine Segment by Application
Figure 3. Global Recombinant Protein Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Protein Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Protein Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Protein Vaccine Revenue in 2021
Figure 9. By Type - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Protein Vaccine Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Protein Vaccine Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 19. US Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 33. China Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Protein Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Recombinant Protein Vaccine by Region, 2021 VS 2028
Figure 50. Recombinant Protein Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Recombinant Protein Vaccine Segment by Type
Figure 2. Recombinant Protein Vaccine Segment by Application
Figure 3. Global Recombinant Protein Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Protein Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Protein Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Protein Vaccine Revenue in 2021
Figure 9. By Type - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Protein Vaccine Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Protein Vaccine Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 19. US Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 33. China Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Protein Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Protein Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Protein Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Protein Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Recombinant Protein Vaccine by Region, 2021 VS 2028
Figure 50. Recombinant Protein Vaccine Industry Value Chain
Figure 51. Marketing Channels
